The fake Ozempic warning was issued after the FDA seized thousands of units

The US Food and Drug Administration is advising extra precautions after seizing thousands of units of counterfeit Ozempic, according to a notice issued Thursday.

Imitation drugs have been linked to five cases of illness so far, the agency said, but none have been reported as serious. Those who used the fake doses reported adverse reactions consistent with the real product, including nausea, vomiting, diarrhea, abdominal pain and constipation.

While the FDA and Ozempic’s manufacturer, Novo Nordisk, have already collected and tested thousands of samples, they warn that some counterfeit products can still be purchased.

Consequently, wholesalers, retail pharmacies, health care practitioners and patients are advised to check any semaglutide they have received to ensure they are not part of the bogus supply, which is labeled with lot number NAR0074 and serial number 430834149057.

Products labeled with lot number NAR0074 and serial number 430834149057 should not be used or sold.

Celebs and Ozempics:Oprah Winfrey’s revelation about using weight loss drugs was a game changer. Here’s why.

Watch out for fakes

The FDA recommends that retail pharmacies purchase genuine Ozempic only through authorized Novo Nordisk distributors.

The FDA and Novo Nordisk are currently analyzing the collected samples to determine their content, safety and effectiveness. So far, they have determined that the products’ pen labels, healthcare professional and patient information and the carton the medicine comes in are all fake.

Importantly, the needles were also found to be counterfeit, meaning their sterility could not be confirmed and could pose a higher risk of infection to patients.

#fake #Ozempic #warning #issued #FDA #seized #thousands #units
Image Source :

Leave a Comment